Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05161858 · ClinicalTrials.gov registry record

Longitudinal Characterization of Respiratory Tract Exacerbations and Treatment Responses in Primary Ciliary Dyskinesia

A clinical trial of Primary Ciliary Dyskinesia and Kartagener Syndrome, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
105
Enrollment target
7
Study locations

NCT05161858 is a study of Primary Ciliary Dyskinesia and Kartagener Syndrome that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 105 participants, above the 95-participant average among 7 other Primary Ciliary Dyskinesia trials with a reported enrollment target (11% higher). The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05161858, a study of Primary Ciliary Dyskinesia and Kartagener Syndrome, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
105 participants
Enrollment target
7
Study locations

Study Summary

The overall objective of this longitudinal, observational study is to provide information needed to inform the design of future interventional trials of respiratory exacerbation prevention and treatment in children and adults with primary ciliary dyskinesia (PCD).

Conditions Studied

Primary Ciliary Dyskinesia Kartagener Syndrome

Study Locations (7)

California

  • Stanford University - Palo Alto

Colorado

  • Children's Hospital Colorado - Aurora

Missouri

  • Washington University in St. Louis - St Louis

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Washington

  • Seattle Children's Hospital - Seattle

Ontario

  • The Hospital for Sick Children - Toronto

Quebec

  • McGill University - Montreal

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2022-03-29
Est. Completion 2025-09-30

Sponsor

University of North Carolina, Chapel Hill

1,109 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05161858

The ClinicalTrials.gov registry entry for NCT05161858 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 95-participant average among 7 other Primary Ciliary Dyskinesia trials with a reported enrollment target (11% higher). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Primary Ciliary Dyskinesia appearing as the primary indexed condition, and to 0 interventions.

NCT05161858 reports 7 study locations spanning 7 distinct geographic areas - top geographies include California, Colorado, Missouri.

Frequently Asked Questions

What is clinical trial NCT05161858 about?

NCT05161858 is a clinical study titled "Longitudinal Characterization of Respiratory Tract Exacerbations and Treatment Responses in Primary Ciliary Dyskinesia". The overall objective of this longitudinal, observational study is to provide information needed to inform the design of future interventional trials of respiratory exacerbation prevention and treatment in children and adults with primary ciliary dyskinesia (PCD).

What is the current status of trial NCT05161858?

This trial is currently completed. The enrollment target is 105 participants. The study started on 2022-03-29. Estimated completion is 2025-09-30.

What conditions does trial NCT05161858 study?

This clinical trial studies the following conditions: Primary Ciliary Dyskinesia, Kartagener Syndrome.

Who is sponsoring clinical trial NCT05161858?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05161858 being conducted?

This trial has 7 study locations across California, Colorado, Missouri, North Carolina, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Primary Ciliary Dyskinesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Primary Ciliary Dyskinesia

All registered trials for this condition

Kartagener Syndrome

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.